Market Access Why 70% of pharma partnership spend misses patients Finding a start-up or building an app is the cheap part; combining capabilities into something that scales across markets is the expensive part.
Market Access Capital discipline in biotech: Building enduring companies w... Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.
R&D Closed & Collaborative H2 2025: Mergers, acquisitions, partn... The second half of 2025 showed pharma and healthcare leaning into partnerships that de‑risk innovation and compress time to market.
Market Access Women's health: Predictions for 2026 A forward glance at new funding vehicles, national strategies, and innovative solutions reshaping the underlying infrastructure of women's care.
Market Access VuuAI and Amiculum partner to transform content engagement i... Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat
Digital Sponsored Reimagining digital health partnerships: A practical guide f... With billions invested and digital health initiatives on the rise, why do so few pharma-tech partnerships achieve lasting success?
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.